Open-label randomized two-way crossover pilot study to estimate the effects of inhaled [Exubera] versus IV [intravenous] infusion of human insulin with regards to glucose disposal in subjects with type 1 diabetes mellitus.

Trial Profile

Open-label randomized two-way crossover pilot study to estimate the effects of inhaled [Exubera] versus IV [intravenous] infusion of human insulin with regards to glucose disposal in subjects with type 1 diabetes mellitus.

Completed
Phase of Trial: Phase III

Latest Information Update: 20 Feb 2008

At a glance

  • Drugs Insulin (Primary)
  • Indications Type 1 diabetes mellitus
  • Focus Pharmacodynamics
  • Sponsors Pfizer
  • Most Recent Events

    • 14 Dec 2007 Status changed from completed to discontinued.
    • 11 Apr 2007 Status changed from in progress to completed.
    • 18 Jan 2007 Status changed from recruiting to in progress.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top